Connect with us

National

NIAID and Moderna scientists describe SARS-CoV-2 vaccine development – News-Medical.Net

Researchers at the National Institute of Allergy and Infectious Diseases and Moderna Inc., have described the potent neutralizing effects of a candidate vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is currently being tested in…

Published

on